Quanterix (QTRX)

• Market cap: $248M
• 1 day: 6.8%
• 5 days: -9.49%
• 1 month: -1.66%
• 3 months: -10.1%
• 6 months: -7.29%
• Year to date: -50.37%
• 1 year: -59.61%
• 5 years: -85.6%
• 10 years: -69.43%
• Sector: Healthcare
• Industry: Medical Devices

About: Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.

Employees: 136